Pharmacokinetics, Pharmacodynamics, Safety, and Preliminary Efficacy of Subcutaneous Injection of SHR-1905 in Adolescent Asthmatic Subjects - an Open-label, Single-dose Phase II Clinical Study

Clinical trial NCT06786455 · COMPLETED

Trial details

NCT number: NCT06786455
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adolescent Asthma

Start date: 2025-01-23
Primary completion: 2025-12-03
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.